Related Experiment Video
Updated: Mar 11, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome
Peminda K Cabandugama1, Michael J Gardner1, James R Sowers2
1Division of Endocrinology, Department of Medicine, Diabetes and Cardiovascular Center, University of Missouri, D109 Diabetes Center UHC, One Hospital Drive, Columbia, MO 65212, USA.
Insights
Obesity and insulin resistance drive cardiorenal metabolic syndrome (CRS) and hypertension. This review explores how these factors, along with renin-angiotensin-aldosterone system activity, contribute to endothelial dysfunction and high blood pressure.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Hypertension Research
Background:
- Over 50 million Americans have elevated blood pressure (≥120/80 mm Hg).
- Obesity is a primary driver of cardiorenal metabolic syndrome (CRS).
- Hypertension and CRS are frequently associated with insulin resistance.
Purpose of the Study:
- To review the literature on the links between hypertension and CRS.
- To focus on the roles of insulin resistance, obesity, and oxidative stress in hypertension pathogenesis.
Main Methods:
- Literature review and synthesis.
- Focus on pathophysiologic mechanisms linking hypertension and CRS.
Main Results:
- Obesity and insulin resistance are key contributors to CRS and hypertension.
- Renin-angiotensin-aldosterone system (RAAS) activity promotes oxidative stress.
- Oxidative stress and RAAS contribute to endothelial dysfunction and hypertension.
Conclusions:
- Insulin resistance and obesity are central to hypertension and CRS.
- RAAS-mediated oxidative stress exacerbates endothelial dysfunction.
- Understanding these links is crucial for managing hypertension and metabolic syndrome.
Abstract:
In the United States, more than 50 million people have blood pressure at or above 120/80 mm Hg. All components of cardiorenal metabolic syndrome (CRS) are linked to metabolic abnormalities and obesity. A major driver for CRS is obesity. Current estimates show that many of those with hypertension and CRS show some degree of systemic and cardiovascular insulin resistance. Several pathophysiologic factors participate in the link between hypertension and CRS. This article updates recent literature with a focus on the function of insulin resistance, obesity, and renin angiotensin aldosterone system-mediated oxidative stress on endothelial dysfunction and the pathogenesis of hypertension.
Related Concept Videos
Hormonal Regulation
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension and Regulation of Blood Pressure

